DXR

DAXOR CORP

• PUBT·04/28 12:08

  Daxor to exhibit Blood Volume Analyzer at MedAxiom CV Transforum Spring’26

• Reuters·04/10 17:54

  Daxor CEO Michael Feldschuh buys 1,000 shares for $9,070

• TipRanks·04/08 12:45

  Lake Street Remains a Buy on Daxor (DXR)

• Reuters·03/31 22:29

  Daxor CFO Robert J. Michel acquires 1,000 common shares for $9,900

• Reuters·03/26 12:04

  Daxor announces SCCM 2026 clinical data; BVA detects 20% per hour median albumin escape rate due to weak correlations in capillary leak indexes

• TipRanks·03/17 12:25

  Daxor to showcase next-gen portable BVA at ACC.26 session

• Benzinga·03/17 12:08

  Daxor To Showcase New, Rapid, Portable Blood Volume Analyzer At ACC.26 Annual Scientific Session

• Reuters·03/17 12:05

  Daxor to exhibit portable Blood Volume Analyzer at ACC Annual Scientific Session

• Reuters·03/10 12:04

  Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress

• TipRanks·03/07 21:15

  Maxim Group Sticks to Its Buy Rating for Daxor (DXR)

• TipRanks·03/05 14:11

  Analysts Are Bullish on These Healthcare Stocks: Niagen Bioscience (NAGE), Daxor (DXR)

• Seeking Alpha·03/03 20:43

  Daxor reports FY results

• TipRanks·03/03 13:51

  Daxor issues update in Letter to Shareholders

• Reuters·03/03 13:33

  BRIEF-Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders

• Reuters·03/03 13:31

  Daxor Reports 45% Revenue Growth in Operating Division for 2025